Sweet Comfort

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for use in adults and children aged 12 years and older for the application on the throat and chest. It should be applied in a thick layer and may be covered with a warm, dry cloth if desired. It is recommended that clothing around the throat and chest be loose to facilitate the inhalation of vapors.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The recommended dosage for the medication is up to three times daily, or as directed by a healthcare professional. For children under 12 years of age, it is advised to consult a doctor prior to administration to determine the appropriate dosage and ensure safety.

Contraindications

There are no specific contraindications identified for this product. However, the following precautions should be observed to ensure safe use:

Heating the product is not recommended. It should not be heated, microwaved, or used near an open flame, as these actions may lead to hazardous conditions. Additionally, the product should not be added to hot water or any container where heating water is involved, as this may cause splattering and result in burns.

Furthermore, it is advised to avoid sun tanning or the use of tanning beds for 3-4 days following application to prevent adverse reactions.

Warnings and Precautions

For external use only; ingestion or nasal application is strictly prohibited. The product is flammable; therefore, it must be kept away from fire or flame to prevent any hazardous incidents.

In the event of accidental ingestion, it is imperative to seek emergency medical assistance immediately or contact a Poison Control Center without delay.

Healthcare professionals should advise patients to discontinue use and consult a physician if a cough persists for more than one week, recurs, or is accompanied by symptoms such as fever, rash, or a persistent headache. A persistent cough may indicate an underlying serious condition that requires further evaluation and management.

Side Effects

Patients using this product should be aware of several important warnings and potential adverse reactions. This product is intended for external use only and should not be ingested or placed in the nostrils. It is also flammable; therefore, it should be kept away from fire or flame.

In clinical practice, patients are advised to stop using the product and consult a healthcare professional if a cough persists for more than one week, tends to recur, or is accompanied by fever, rash, or a persistent headache. A persistent cough may indicate a serious underlying condition that requires medical evaluation.

Before using this product, patients should seek medical advice if they have a persistent or chronic cough, such as that associated with smoking, asthma, or emphysema. Additionally, individuals with a cough accompanied by excessive phlegm (mucus) or those with a history of epilepsy should consult a healthcare provider prior to use.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Sweet Comfort (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Children under 12 years of age should consult a healthcare professional before use. For adults and children aged 12 years and older, the product is to be applied in a thick layer on the throat and chest, with a maximum frequency of three times daily or as directed by a healthcare provider.

It is essential to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should not use this product. The potential risks associated with the use of this product during pregnancy or lactation have not been established, and its safety in these populations has not been evaluated. Therefore, healthcare professionals are advised to consider alternative treatments for women who are pregnant or nursing.

Lactation

Lactating mothers are advised against the use of this product during breastfeeding. There is no available data on the excretion of the product in human milk or its effects on breastfed infants. Therefore, caution is warranted, and alternative treatments should be considered for lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may indicate an overdose. These may include, but are not limited to, altered mental status, cardiovascular instability, or gastrointestinal disturbances.

Management of an overdose should be guided by the clinical presentation of the patient. Supportive care is paramount, and symptomatic treatment should be initiated as necessary. It is recommended that healthcare professionals consult local poison control centers or relevant toxicology resources for further guidance on the management of overdose cases.

In summary, while specific overdosage data is not available, healthcare professionals should exercise caution, remain alert to the signs of overdose, and implement appropriate management strategies as needed.

Nonclinical Toxicology

If pregnant or breastfeeding, the use of this product is contraindicated due to potential teratogenic effects. No specific non-teratogenic effects or additional nonclinical toxicology details have been provided. Furthermore, there are no specific findings related to animal pharmacology and toxicology available in the current data.

Postmarketing Experience

No postmarketing experience details are provided in the insert for SPL code 90375-7.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to inform patients that they should discontinue use and consult a doctor if their cough persists for more than one week, recurs, or is accompanied by symptoms such as fever, rash, or a persistent headache, as these may indicate a serious underlying condition.

Patients should be cautioned against certain practices while using this product. Specifically, they should not heat, microwave, or use the product near an open flame. Additionally, they should avoid adding the product to hot water or any container where water is being heated, as this may cause splattering and result in burns. Furthermore, patients are advised to refrain from sun tanning or using tanning beds for 3-4 days following the use of the product.

Healthcare providers should also encourage patients to consult a doctor prior to use if they have a persistent or chronic cough, such as that associated with smoking, asthma, or emphysema, or if their cough is accompanied by excessive phlegm (mucus). Patients with a history of epilepsy should also seek medical advice before using the product.

Storage and Handling

The product is available in various packaging configurations, and the National Drug Code (NDC) numbers are provided for reference. It is essential to store the product in a tightly closed container to maintain its integrity. The recommended storage condition is at room temperature, away from heat sources.

Additionally, the organization supports recycling initiatives and encourages healthcare professionals to recycle the packaging where possible.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Sweet Comfort, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)